James R. Tobin
Director · GLOBUS MEDICAL INC
IndividualSelling only
- 2025
- Sep 16, 2026
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies James R. Tobin files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Stephen T. Zarrilli - $4.28M in GMED purchases and sales in the last 12 months
- David D. Davidar - $4.17M in GMED purchases and sales in the last 12 months
- Kelly Huller - $3.44M in GMED purchases and sales in the last 12 months
- Kyle Kline - $2.03M in GMED purchases and sales in the last 12 months
- David Weill - $1.33M in TMDX purchases and sales in the last 12 months
- Gerardo Hernandez - $1.25M in TMDX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is James R. Tobin?
James R. Tobin is a corporate insider, tracked as Director of GLOBUS MEDICAL INC (GMED). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has James R. Tobin submitted recently?
2 primary Form 4 filings in the last 90 days, covering 2 companies.
Has James R. Tobin been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($2.24M) across all tracked filings.
